Thiol-Functionalized, Antioxidant, and Osteogenic Mesoporous Silica Nanoparticles for Osteoporosis
- PMID: 37172017
- DOI: 10.1021/acsbiomaterials.3c00479
Thiol-Functionalized, Antioxidant, and Osteogenic Mesoporous Silica Nanoparticles for Osteoporosis
Abstract
Osteoporosis is a chronic bone disorder characterized by decreased bone mass, leading to brittle bones and fractures. Oxidative stress has been identified as the most profound trigger for the initiation and progression of osteoporosis. Current treatment strategies do not induce new bone formation and fail to address a high level of reactive oxygen species (ROS). Mesoporous silica nanoparticles (MSNs) have been explored in bone tissue regeneration owing to their inherent osteogenic property, but they lack antioxidant and cell adhesion properties, required in such applications. We have developed thiolated, bioactive mesoporous silica nanoparticles (MSN-SH) to address this challenge. MSNs were fabricated using the Stöber method, and 11% of the surface was functionalized post-synthesis with thiol groups using MPTMS to obtain MSN-SH. The particle size measured by the dynamic light scattering technique was found to be around 300 nm. The surface morphology was investigated using HR-TEM, and their physical and chemical properties were characterized using various spectroscopic techniques. They exhibited more than 90% antioxidant activity, neutralized ROS formed in cells, and provided protection against ROS-induced cell damage. The cell viability assay in murine osteoblast precursor cells (MC3T3) showed that MSN-SH is cell-proliferative in nature with 140% cell viability. Osteogenic potential was evaluated by measuring the ALP activities, calcium deposition, and gene expression levels of osteogenic markers, such as RUNX2, ALP, OCN, and OPN, and results revealed that MSN-SH increases calcium deposition and induces osteogenesis through upregulation of osteogenic genes and markers without the involvement of any osteogenic supplements. Besides promoting osteogenesis, MSN-SH was found to inhibit osteoclastogenesis. The nanomaterial was found to be regenerative in nature, and it stimulated migration of osteoblast cells and caused a complete wound closure within 48 h. We were able to achieve a multifunctional nanomaterial by simply modifying the surface. MSNs have been explored for bone tissue engineering/osteoporosis as a composite system incorporating metals, like gold and cerium, or as a nanocarrier loaded with growth factors or active drugs. This study offers a simple and economical method to enhance the existing properties of MSNs and impart new activities by a single-step surface modification. It can be concluded that MSN-SH holds promise as a complementary and alternate treatment for osteoporosis along with the standardized therapy.
Keywords: antioxidant; bone mineralization; osteoporosis; silica nanoparticles; thiolation.
Similar articles
-
Nanoceria provides antioxidant and osteogenic properties to mesoporous silica nanoparticles for osteoporosis treatment.Acta Biomater. 2021 Mar 1;122:365-376. doi: 10.1016/j.actbio.2020.12.029. Epub 2021 Jan 5. Acta Biomater. 2021. PMID: 33359295
-
Poly-l-lactic acid scaffold incorporated chitosan-coated mesoporous silica nanoparticles as pH-sensitive composite for enhanced osteogenic differentiation of human adipose tissue stem cells by dexamethasone delivery.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):4020-4029. doi: 10.1080/21691401.2019.1658594. Artif Cells Nanomed Biotechnol. 2019. PMID: 31595797
-
Accelerated Bone Regeneration by Gold-Nanoparticle-Loaded Mesoporous Silica through Stimulating Immunomodulation.ACS Appl Mater Interfaces. 2019 Nov 6;11(44):41758-41769. doi: 10.1021/acsami.9b16848. Epub 2019 Oct 28. ACS Appl Mater Interfaces. 2019. PMID: 31610117
-
Modulating Osteoimmune Responses by Mesoporous Silica Nanoparticles.ACS Biomater Sci Eng. 2022 Oct 10;8(10):4110-4122. doi: 10.1021/acsbiomaterials.1c00899. Epub 2021 Nov 13. ACS Biomater Sci Eng. 2022. PMID: 34775744 Review.
-
Mesoporous silica nanoparticles for tissue-engineering applications.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Nov;11(6):e1573. doi: 10.1002/wnan.1573. Epub 2019 Jul 11. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019. PMID: 31294533 Review.
Cited by
-
Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases.J Nanobiotechnology. 2024 May 15;22(1):252. doi: 10.1186/s12951-024-02501-9. J Nanobiotechnology. 2024. PMID: 38750509 Free PMC article. Review.
-
Inhibitory impact of a mesoporous silica nanoparticle-based drug delivery system on Porphyromonas gingivalis-induced bone resorption.J Mater Sci Mater Med. 2024 Sep 30;35(1):56. doi: 10.1007/s10856-024-06827-6. J Mater Sci Mater Med. 2024. PMID: 39347836 Free PMC article.
-
In-Bath 3D Printing of Anisotropic Shape-Memory Cryogels Functionalized with Bone-Bioactive Nanoparticles.ACS Appl Mater Interfaces. 2024 Apr 17;16(15):18386-18399. doi: 10.1021/acsami.3c18290. Epub 2024 Apr 9. ACS Appl Mater Interfaces. 2024. PMID: 38591243 Free PMC article.
-
Three-Dimensionally Printed Scaffolds and Drug Delivery Systems in Treatment of Osteoporosis.Biomimetics (Basel). 2025 Jul 1;10(7):429. doi: 10.3390/biomimetics10070429. Biomimetics (Basel). 2025. PMID: 40710240 Free PMC article. Review.
-
Mechanism of MiR-145a-3p/Runx2 pathway in dexamethasone impairment of MC3T3-E1 osteogenic capacity in mice.PLoS One. 2024 Nov 19;19(11):e0309951. doi: 10.1371/journal.pone.0309951. eCollection 2024. PLoS One. 2024. PMID: 39561180 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous